Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nevin A John

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
BMJ (Clinical Research Ed.)|November 29, 2018
Disease-modifying therapies for multiple sclerosisFloriana De Angelis, Nevin A John, Wallace J Brownlee
International Journal of Molecular Sciences|December 11, 2025
The Potential of β-Synuclein-Specific Regulatory T Cell Therapy as a Treatment for Progressive Multiple SclerosisGrace E Osmond, Nevin A John, Yi Tian Ting, et al.
Journal of the Neurological Sciences|October 17, 2019
Screening for urinary tract colonisation prior to corticosteroid administration in acute multiple sclerosis relapses: Validation of an updated algorithmFergus O'Herlihy, Nevin A John, Vivien Li, et al.
European Journal of Neurology|February 10, 2026
Vascular Comorbidities and an Increased Comorbidity Score Are Associated With Disability and Disability Progression in Secondary Progressive Multiple SclerosisNevin A John, Yingtong Li, Floriana De Angelis, et al.
European Journal of Neurology|December 18, 2024
Vascular risk factors are associated with grey matter atrophy in secondary progressive multiple sclerosisNevin A John, Yingtong Li, Floriana De Angelis, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 23, 2025
Neurofilament heavy chain in secondary progressive multiple sclerosisFloriana De Angelis, Francesca Ammoscato, Richard A Parker, et al.
Journal of Magnetic Resonance Imaging : JMRI|October 3, 2023
Longitudinal Metabolite Changes in Progressive Multiple Sclerosis: A Study of 3 Potential Neuroprotective TreatmentsNevin A John, Bhavana S Solanky, Floriana De Angelis, et al.
Therapeutic Advances in Neurological Disorders|April 1, 2026
Comparative effectiveness of anti-CD20 therapies and S1P receptor modulators in late-onset multiple sclerosis: real-world evidence from the MSBase registryAndrea Surcinelli, Tomas Kalincik, Izanne Roos, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 7, 2025
Four years on: Pregnancy and birth outcomes reported in the MSBase pregnancy, neonatal outcomes, and Women's Health Registry (2020-2024)Vilija G Jokubaitis, Raed Alroughani, Ayse Altintas, et al.
JAMA Network Open|September 15, 2025
Pregnancy-Related Disease Outcomes in Women With Moderate to Severe Multiple Sclerosis DisabilityJessica Shipley, Heidi N Beadnall, Paul G Sanfilippo, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
BMJ (Clinical Research Ed.)|November 29, 2018
Disease-modifying therapies for multiple sclerosisFloriana De Angelis, Nevin A John, Wallace J Brownlee
International Journal of Molecular Sciences|December 11, 2025
The Potential of β-Synuclein-Specific Regulatory T Cell Therapy as a Treatment for Progressive Multiple SclerosisGrace E Osmond, Nevin A John, Yi Tian Ting, et al.
Journal of the Neurological Sciences|October 17, 2019
Screening for urinary tract colonisation prior to corticosteroid administration in acute multiple sclerosis relapses: Validation of an updated algorithmFergus O'Herlihy, Nevin A John, Vivien Li, et al.
European Journal of Neurology|February 10, 2026
Vascular Comorbidities and an Increased Comorbidity Score Are Associated With Disability and Disability Progression in Secondary Progressive Multiple SclerosisNevin A John, Yingtong Li, Floriana De Angelis, et al.
European Journal of Neurology|December 18, 2024
Vascular risk factors are associated with grey matter atrophy in secondary progressive multiple sclerosisNevin A John, Yingtong Li, Floriana De Angelis, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 23, 2025
Neurofilament heavy chain in secondary progressive multiple sclerosisFloriana De Angelis, Francesca Ammoscato, Richard A Parker, et al.
Journal of Magnetic Resonance Imaging : JMRI|October 3, 2023
Longitudinal Metabolite Changes in Progressive Multiple Sclerosis: A Study of 3 Potential Neuroprotective TreatmentsNevin A John, Bhavana S Solanky, Floriana De Angelis, et al.
Therapeutic Advances in Neurological Disorders|April 1, 2026
Comparative effectiveness of anti-CD20 therapies and S1P receptor modulators in late-onset multiple sclerosis: real-world evidence from the MSBase registryAndrea Surcinelli, Tomas Kalincik, Izanne Roos, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 7, 2025
Four years on: Pregnancy and birth outcomes reported in the MSBase pregnancy, neonatal outcomes, and Women's Health Registry (2020-2024)Vilija G Jokubaitis, Raed Alroughani, Ayse Altintas, et al.
JAMA Network Open|September 15, 2025
Pregnancy-Related Disease Outcomes in Women With Moderate to Severe Multiple Sclerosis DisabilityJessica Shipley, Heidi N Beadnall, Paul G Sanfilippo, et al.
Pageof 2